Ticker: DYN

Company: Dyne Therapeutics, Inc.

Person: Jason P Rhodes, director

Transaction date: April 20, 2026

Reporting date: April 22, 2026

Average share price: 19.749908006932742

Sold 834302.0 shares for 16477387.75